Tumor blood flow modifying effects of electrochemotherapy: A potential vascular targeted mechanism

Radiology and Oncology

Volumn 37, Issue 1, 2003, Pages

  Serša, Gregor ^a   Čemažar, Maja ^a   Miklavčič, Damijan ^b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bleomycin; Cisplatin; Drug delivery systems; Electroporation; Sarcoma experimental drug therapy blood supply

Indexed keywords

BLEOMYCIN; CISPLATIN; DISULFINE BLUE; DYE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL SURVIVAL; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTROCHEMOTHERAPY; ELECTROPORATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; STAINING; SYSTEMIC THERAPY; TECHNIQUE; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR CELL; TUMOR CELL DESTRUCTION; TUMOR GROWTH; TUMOR VOLUME;

EID: 0037366352     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mir LM, Orlowski S. Mechanisms of electrochemotherapy. Adv Drug Deliver Rev 1999; 35: 107-18.
2. Serša G, Čemažar M, Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995; 55: 3450-5.
3. Heller R, Gilbert R, Jaroszeski MJ. Clinical application of electrochemotherapy. Adv Drug Deliver 1999; 35: 119-29.
4. Serša G, Štabuc B, Čemažar M, Miklavčič D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6: 863-7.
5. Serša G, Čemažar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 1999; 35: 672-7.
6. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002; 1569: 51-8.
7. Neumann E, Kakorin S. Digression on membrane electroporation and electroporative delivery of drugs and genes. Radiol Oncol 1998; 32: 7-17.
8. Chaplin DJ, Hill SA, Bell KM, Tozer GM. Modification of tumor blood flow: Current status and future direction. Sem Radiat Oncol 1998; 8: 151-63.
9. Mir LM, Glass LF, Serša G, Teissie J, Domenge C, Miklavčič D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, Belehradek M, Gilbert R, Rols MP, Belehradek JJr, Bachaud JM, DeConti R, Štabuc B, Čemažar M, Coninx P, Heller R. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336-42.
10. Serša G. Electrochemotherapy: Animal work review. In: Jaroszeski MJ, Heller R, Gilbert R, editors. Electrochemotherapy, electrogenetherapy and transdermal drug delivery. Electrically mediated delivery of molecules to cells. Totowa: Humana Press; 2000. p. 119-36.
11. Čemažar M, Miklavčič D, Ščančar J, Dolžan V, Golouh R, Serša G. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 1999; 79: 1386-91.
12. Serša G, Čemažar M, Miklavčič D, Chaplin DJ. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 1999; 19 (5B): 4017-22.
13. Čemažar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, Serša G. Electroporation of human microvascular endothelial cells: evidence for an antivascular mechanism of electrochemotherapy. Br J Cancer 2001; 84: 565-70.